Reed Chrystal M, Dewar Sandra, Fried Itzhak, Engel Jerome, Eliashiv Dawn
Department of Neurology, Cedars Sinai Medical Center, Los Angeles, CA, United States.
Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States.
Clin Neurol Neurosurg. 2017 Dec;163:110-115. doi: 10.1016/j.clineuro.2017.10.023. Epub 2017 Oct 23.
Resective epilepsy surgery has been shown to have up to 70-80% success rates in patients with intractable seizure disorder. Around 20-30% of patients with Engel Classification III and IV will require reevaluation for further surgery. Common reasons for first surgery failures include incomplete resection of seizure focus, incorrect identification of seizure focus and recurrence of tumor.
Clinical chart review of seventeen patients from a single adult comprehensive epilepsy program who underwent reoperation from 2007 to 2014 was performed. High resolution Brain MRI, FDG-PET, Neuropsychometric testing were completed in all cases in both the original surgery and the second procedure. Postoperative outcomes were confirmed by prospective telephone follow up and verified by review of the patient's electronic medical records. Outcomes were classified according to the modified Engel classification system: Engel classes I and II are considered good outcomes.
A total of seventeen patients (involving 10 females) were included in the study. The average age of patients at second surgery was 42 (range 23-64 years). Reasons for reoperation included: incomplete first resection (n=13) and recurrence of tumor (n=4). Median time between the first and second surgery was 60 months. After the second surgery, ten of the seventeen patients (58.8%) achieved seizure freedom (Engel Class I), in agreement with other published reports. Of the ten patients who were Engel Class I, seven required extension of the previous resection margins, while three had surgery for recurrence of previously partially resected tumor.
We conclude that since the risk of complications from reoperation is low and the outcome, for some, is excellent, consideration of repeat surgery is justified.
对于难治性癫痫患者,切除性癫痫手术已显示出高达70%-80%的成功率。约20%-30%的恩格尔分类为III级和IV级的患者需要重新评估以进行进一步手术。首次手术失败的常见原因包括癫痫病灶切除不完全、癫痫病灶识别错误和肿瘤复发。
对来自一个成人综合癫痫项目的17例在2007年至2014年间接受再次手术的患者进行临床病历回顾。所有病例在初次手术和第二次手术时均完成了高分辨率脑部MRI、FDG-PET和神经心理测试。术后结果通过前瞻性电话随访得到确认,并经患者电子病历复查核实。结果根据改良的恩格尔分类系统进行分类:恩格尔I级和II级被视为良好结果。
本研究共纳入17例患者(其中10例为女性)。患者第二次手术时的平均年龄为42岁(范围23-64岁)。再次手术的原因包括:初次切除不完全(n=13)和肿瘤复发(n=4)。首次手术与第二次手术之间的中位时间为60个月。第二次手术后,17例患者中有10例(58.8%)实现了无癫痫发作(恩格尔I级),这与其他已发表的报告一致。在这10例恩格尔I级患者中,7例需要扩大先前的切除边缘,而3例因先前部分切除的肿瘤复发而接受手术。
我们得出结论,由于再次手术的并发症风险较低,且对一些患者来说结果极佳,因此考虑再次手术是合理的。